Hongbo Jiang
Medical School
University of Chinese Academy of Sciences
Shanghai
Language: Chinese, English
Contact
Biological Sciences Technology Novelty Consulting Patent Analysis Biotechnology Life Sciences Science Policy Intellectual Property Cell Therapy Bioinformatics Health Industry
Areas of Focus
  • Biological Sciences
  • Technology Novelty Consulting
  • Patent Analysis
  • Biotechnology
  • Life Sciences
  • Science and Technology Policy
  • Intellectual Property
  • Cell Therapy
  • Bioinformatics
  • Health Industry
Work Experience
  • 2019-05~Present - Chinese Academy of Sciences, Shanghai Institute of Nutrition and Health - Technology Novelty Consulting Center
  • 2003-07~2019-04 - Chinese Academy of Sciences, Shanghai Institutes for Biological Sciences - Technology Novelty Consulting Center
  • 1992-08~1996-08 - Duchang Middle School, Jiangxi Province - Biology Teacher
Academic Background & Achievements
  • 1999-09--2003-06 PhD: East China Normal University, School of Life Sciences
  • 1996-09--1999-06 Master's: East China Normal University, School of Life Sciences
  • 1988-09--1992-06 Bachelor's: Jiangxi University (now Nanchang University), Department of Biology
Publications
  • Research and Development Trends in Aging Biology in 2023, Hongbo Jiang, 2024
  • Development Trends in Computational Biology in 2023, Hongbo Jiang, 2024
  • TRIZ-based Maturity Prediction of Cell Therapy Technology, Hongbo Jiang, 2023
  • Development Progress of Osteoarthritis Treatment Drugs at Different R&D Stages, Hongbo Jiang, 2023
  • Challenges and Responses to Coordinated Development of the Yangtze River Delta Industrial Chain under the New Development Pattern, Hongbo Jiang, 2022
  • Analysis of the Evolution of Industrial Technology Innovation Cooperation Networks from a Patent Perspective: A Case Study of Tumor Vaccines, Hongbo Jiang, 2022
  • Global Bispecific Antibody Drug Development Landscape, Hongbo Jiang, 2021
  • Hotspot Analysis of Elderly Rehabilitation Nursing Technology and Products Based on Patent Analysis, Hongbo Jiang, 2020
  • Development Status and Trend Analysis of Oligonucleotide Therapies, Hongbo Jiang, 2018
  • The Research Status of Immune Checkpoint Blockade by Anti-CTLA4 and Anti-PD1/PD-L1 Antibodies in Tumor Immunotherapy in China: A Bibliometrics Study, Hongbo Jiang, 2018
  • Development Status and Trend Analysis of Immune System Cell Therapies, Hongbo Jiang, 2018
  • Scale Development and Industrial Situation of Bulk Products such as Antibiotics, Amino Acids, and Vitamins, Hongbo Jiang, 2012
  • Bridging the Gap Between Policy Implementation and Goals: A Study on the Use of Policy Tools in the Field of Science and Technology, Hongbo Jiang, 2012
  • Patent Analysis of Microbial Resources, Hongbo Jiang, 2011
  • Patent Analysis and Countermeasures for Biopharmaceuticals, Hongbo Jiang, 2011
  • Patent Analysis of Microalgae Development and Application, Hongbo Jiang, 2011
  • Increasing Investment in Science and Technology, Paying More Attention to Original Innovation, Human Resources, SMEs, and Soft Power: Interpretation of the EU's Seventh Framework Program 2011 Investment Budget Plan, Hongbo Jiang, 2011
  • Patent Analysis of Crop Genetic Engineering Technology, Hongbo Jiang, 2010
  • Current Status and Development Trends of Antibody Drug Research and Development, Hongbo Jiang, 2009
  • New Progress in Research and Application of Bioreactors, Hongbo Jiang, 2009
  • Current Status and Commercial Prospects of Energy Crops, Hongbo Jiang, 2009
  • Current Status and Development Trends of Gene Therapy Research, Hongbo Jiang, 2009
  • Analysis of Stem Cell Therapy Policies and Plans in Various Countries, Hongbo Jiang, 2009
Awards
  • Shanghai Science and Technology Progress Award (2005): First Prize, Provincial Level
Post a Project

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.